Samarth Kulkarni, CEO, CRISPR Therapeutics

preview_player
Показать описание
Kulkarni discusses the current state of biotechnology, the opportunities for CRISPR gene-editing therapies – and their implications for the larger pharmaceutical industry – as well as his experience leading a young company at the cutting edge of technology.

Record Date: 2/14/23
Рекомендации по теме